Literature DB >> 24666472

The new American guidelines on hypertension: a favorable opinion.

Giuseppe Mancia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24666472      PMCID： PMC8031515          DOI： 10.1111/jch.12311

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  13 in total

1.  Better compliance to antihypertensive medications reduces cardiovascular risk.

Authors:  Giovanni Corrao; Andrea Parodi; Federica Nicotra; Antonella Zambon; Luca Merlino; Giancarlo Cesana; Giuseppe Mancia
Journal:  J Hypertens       Date:  2011-03       Impact factor: 4.844

2.  Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

3.  Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management--is nice always good?

Authors:  Alberto Zanchetti; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-04       Impact factor: 4.844

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

6.  Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.

Authors:  Yuquing Zhang; Xuezhong Zhang; Lisheng Liu; Alberto Zanchetti
Journal:  Eur Heart J       Date:  2011-02-22       Impact factor: 29.983

7.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Authors:  Giuseppe Mancia; Stéphane Laurent; Enrico Agabiti-Rosei; Ettore Ambrosioni; Michel Burnier; Mark J Caulfield; Renata Cifkova; Denis Clément; Antonio Coca; Anna Dominiczak; Serap Erdine; Robert Fagard; Csaba Farsang; Guido Grassi; Hermann Haller; Anthony Heagerty; Sverre E Kjeldsen; Wolfgang Kiowski; Jean Michel Mallion; Athanasios Manolis; Krzysztof Narkiewicz; Peter Nilsson; Michael H Olsen; Karl Heinz Rahn; Josep Redon; José Rodicio; Luis Ruilope; Roland E Schmieder; Harry A J Struijker-Boudier; Pieter A van Zwieten; Margus Viigimaa; Alberto Zanchetti
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

10.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

Authors:  Athanase Benetos; Frédérique Thomas; Kathryn E Bean; Louis Guize
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844
View more
  2 in total

1.  Long noncoding RNA MALAT1 polymorphism predicts MACCEs in patients with myocardial infarction.

Authors:  Tong Zhang; Jun-Yi Luo; Fen Liu; Xue-He Zhang; Fan Luo; Yi-Ning Yang; Xiao-Mei Li
Journal:  BMC Cardiovasc Disord       Date:  2022-04-07       Impact factor: 2.298

2.  NFKB1 gene rs28362491 ins/del variation is associated with higher susceptibility to myocardial infarction in a Chinese Han population.

Authors:  Jun-Yi Luo; Yan-Hong Li; Bin-Bin Fang; Ting Tian; Fen Liu; Xiao-Mei Li; Xiao-Ming Gao; Yi-Ning Yang
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.